Wen-jing Wu

836 total citations
12 papers, 681 citations indexed

About

Wen-jing Wu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wen-jing Wu has authored 12 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wen-jing Wu's work include Gastric Cancer Management and Outcomes (3 papers), MicroRNA in disease regulation (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). Wen-jing Wu is often cited by papers focused on Gastric Cancer Management and Outcomes (3 papers), MicroRNA in disease regulation (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). Wen-jing Wu collaborates with scholars based in China, United States and Netherlands. Wen-jing Wu's co-authors include Rui‐Hua Xu, Zhao-Lei Zeng, Dong-liang Chen, Hui Luo, De‐Shen Wang, Dong-sheng Zhang, Chao Ren, Peng Huang, Miao‐Zhen Qiu and Yuhong Li and has published in prestigious journals such as PLoS ONE, Hepatology and Clinical Cancer Research.

In The Last Decade

Wen-jing Wu

12 papers receiving 678 citations

Peers

Wen-jing Wu

ONCOL

PRM

EAS

Xiaofang Ying China

Tommaso Colangelo Italy

J.P. Peyrat France

Ryota Mori Japan

Nicole Grabinski Germany

Bo Pang China

Carmelo Laudanna Italy

Nevin M. Perera United Kingdom

Begoña Colás Spain

Melissa L. Sokolosky United States

Xiaofang Ying China

Wen-jing Wu

397 ×0.9

238 ×1.0

190 ×1.0

ONCOL

87 ×0.7

PRM

56 ×0.7

EAS

Citations per year, relative to Wen-jing Wu Wen-jing Wu (= 1×) peers Xiaofang Ying

Countries citing papers authored by Wen-jing Wu

Since Specialization

Citations

This map shows the geographic impact of Wen-jing Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen-jing Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen-jing Wu more than expected).

Fields of papers citing papers by Wen-jing Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen-jing Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen-jing Wu. The network helps show where Wen-jing Wu may publish in the future.

Co-authorship network of co-authors of Wen-jing Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Wen-jing Wu. A scholar is included among the top collaborators of Wen-jing Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen-jing Wu. Wen-jing Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Yuan, Shuqiang, Wen-jing Wu, Miao‐Zhen Qiu, et al.. (2017). Development and Validation of a Nomogram to Predict the Benefit of Adjuvant Radiotherapy for Patients with Resected Gastric Cancer. Journal of Cancer. 8(17). 3498–3505. 12 indexed citations

Bai, Long, Dong-sheng Zhang, Wen-jing Wu, et al.. (2015). Clinical outcomes of Chinese patients with metastatic colorectal cancer receiving first-line bevacizumab-containing treatment. Medical Oncology. 32(2). 469–469. 9 indexed citations

Chen, Dong-liang, Zhi-qiang Wang, Zhao-Lei Zeng, et al.. (2014). Identification of MicroRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression. Hepatology. 60(2). 598–609. 109 indexed citations

Chen, Weiwei, Feng Wang, Dong-sheng Zhang, et al.. (2014). Primary small cell carcinoma of the esophagus: clinicopathological study of 44 cases. BMC Cancer. 14(1). 222–222. 13 indexed citations

Zeng, Zhao-Lei, Hui Luo, Jing Yang, et al.. (2013). Overexpression of the Circadian Clock Gene Bmal1 Increases Sensitivity to Oxaliplatin in Colorectal Cancer. Clinical Cancer Research. 20(4). 1042–1052. 120 indexed citations

He, Ming-Ming, Wen-jing Wu, Feng Wang, et al.. (2013). S-1-Based Chemotherapy versus Capecitabine-Based Chemotherapy as First-Line Treatment for Advanced Gastric Carcinoma: A Meta-Analysis. PLoS ONE. 8(12). e82798–e82798. 20 indexed citations

Chen, Dong-liang, Zhao-Lei Zeng, Jing Yang, et al.. (2013). L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancer. Journal of Hematology & Oncology. 6(1). 43–43. 58 indexed citations

Qiu, Hai-Bo, Li-Yi Zhang, Chao Ren, et al.. (2013). Targeting CDH17 Suppresses Tumor Progression in Gastric Cancer by Downregulating Wnt/β-Catenin Signaling. PLoS ONE. 8(3). e56959–e56959. 36 indexed citations

Wu, Wen-jing, De‐Shen Wang, Zhao-Lei Zeng, et al.. (2013). CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer. Journal of Translational Medicine. 11(1). 142–142. 118 indexed citations

10.

Chen, Dong-liang, De‐Shen Wang, Wen-jing Wu, et al.. (2012). Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer. Carcinogenesis. 34(4). 803–811. 94 indexed citations

11.

Qiu, Miao‐Zhen, Zhao-Lei Zeng, Hui Luo, et al.. (2012). Copper-transporting P-type adenosine triphosphatase (ATP7A) is associated with platinum-resistance in non-small cell lung cancer (NSCLC). Journal of Translational Medicine. 10(1). 21–21. 46 indexed citations

12.

Wu, Wen-jing, Yan Zhang, Zhao-Lei Zeng, et al.. (2012). β-Phenylethyl isothiocyanate reverses platinum resistance by a GSH-dependent mechanism in cancer cells with epithelial-mesenchymal transition phenotype. Biochemical Pharmacology. 85(4). 486–496. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact